HNWAG
High Net Worth Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-302
| Closed | -$215K | – | 221 |
|
|
2024
Q4 | $215K | Hold |
302
| – | – | 0.06% | 208 |
|
|
2024
Q3 | $317K | Hold |
302
| – | – | 0.09% | 166 |
|
|
2024
Q2 | $317K | Hold |
302
| – | – | 0.1% | 152 |
|
|
2024
Q1 | $291K | Hold |
302
| – | – | 0.09% | 166 |
|
|
2023
Q4 | $265K | Hold |
302
| – | – | 0.1% | 159 |
|
|
2023
Q3 | $249K | Hold |
302
| – | – | 0.1% | 158 |
|
|
2023
Q2 | $217K | Buy |
302
+26
| +9% | +$18.7K | 0.08% | 181 |
|
|
2023
Q1 | $227K | Buy |
276
+26
| +10% | +$21.4K | 0.09% | 168 |
|
|
2022
Q4 | $180K | Hold |
250
| – | – | 0.07% | 195 |
|
|
2022
Q3 | $172K | Hold |
250
| – | – | 0.07% | 194 |
|
|
2022
Q2 | $148K | Hold |
250
| – | – | 0.06% | 209 |
|
|
2022
Q1 | $175K | Hold |
250
| – | – | 0.06% | 200 |
|
|
2021
Q4 | $158K | Buy |
+250
| New | +$158K | 0.06% | 208 |
|